You are here

ESTIMATION OF ANTI-FUNGAL ACTIVITY OF AQUEOUS EXTRACTS OF BROWN SEAWEED, SARGASSUM ILLICIFOLIUM

Journal Name:

Publication Year:

Abstract (2. Language): 
Marine organisms are a novel source of medicines. In this regard the present study aims to evaluate the anti fungal activity of aqueous extract of Brown Seaweed, Sargassumillicifolium on three types of terrestrial, non- pathogenic fungi.The anti-fungal activity of aqueous extract of Sargassumillicifolium of different concentration such as 5%, 10%, 15%, 20%, 25% and controls both positive and negative were carried out against three types of terrestrial, nonpathogenic fungiusing Agar Diffusion Assay.The results indicated that in the negative control and lower concentrations (5%, 10%, 15%) there was no or least amount of antifungal activity which was followed by that of the positive control, Clotrimazole, and the higher concentration of 20% and 25% showed better antifungal activity than that of the patented medicine. This preliminary study indicates that the aqueous extract of Sargassumillicifolium, is indeed endowed with antifungal properties against the three different type of terrestrial non-pathogenic fungus
374-377

REFERENCES

References: 

1) I. Karaman, F. Sahin, M. Güllüce, H. Ögütçü, M.
Sengül and A. Adıgüzel. Antimicrobial activity of
aqueousand methanol extracts of
JuniperusoxycedrusL. JEthnopharmacol85: 231-235
(2003).
2) J. M. Sieburth. Antibacterial substances produced by
marine algae. Developments IndustrMicrobiol5:
1964;124-134.
3) J. L. Reichelt and M. A. Borowitzka. Antimicrobial
activity from marine algae: Results of a large-scale
screening programme. Hydrobiologia 116/117:
158-168 (1984).
4) M. Plaza, S. L. Santoyo, G.G. Jaime Reina, M. Herrero,
F. J. Señorás and E. Ibálnez. Screening for bioactive
compounds from alga. J Pharm Biomed Anal 51:
450-455 (2010).
5) C. Penna, S. Marino, E. Vivot, M. C. Cruan, J. D.
Muñoz, J. Cruañes, G. Ferraro, G. Gutkind and V.
Martino. Antimicrobial activity of Argentine plants
used in the treatment of infectious diseases.
Isolation of active compoundsfrom
Sebastianiabrasiliensis. J Ethnopharmacol 77:37-40
(2001).
6) B. H. Bowman, T. J. White and J. Taylor. Human
pathogeneic fungi and their close nonpathogenic
relatives. WMolPhylogenetEvol 6(1): 1996; 89-96.
7) R. K. Finn. Theory of Agar Diffusion Methods for
Bioassay.Anal Chem 31 (6): 1959;975–977.
8) D.J.Faulkner. Marine natural products. Nat Prod
Rep19: 1–48(2002).
9) A. J. Smit. Medicinal and pharmaceutical uses of
seaweed natural products: A review. J
ApplPhycol16:245–262(2004).
10) R. C. Pereira, D. N. Cavalcanti and V. L. Teixeira.
Effects ofsecondary metabolites from the tropical
Brazilian brown alga Dictyotamenstrualis on the
amphipod Parhyalehawaiensis. MarEcolProgSer
205: 95–100(2000).
11) T. M. Schmitt, M. E. Hay and N. Lindquist.
Constraints on chemical mediated co-evolution;
multiple functions for seaweed secondary
metabolites. Ecology 76: 107–123(1995).
12) T. M. Schmitt, N. Lindquist and M. E. Hay. Seaweed
secondary metabolites as antifoulants: effects of
Dictyota spp. Diterpeneson survivorship,
settlement, and development of marineinvertebrate
larvae. Chemoecology 8: 125–131(1998).
13) V. J. Paul Ecological Roles of Marine Natural
Products. Cornell University Press, New York 1992.
14) J. Mc. N.Sieburth and J. T.Conover. Antifouling in
Sargassumnatans: re-recognition of tannins activity.
ProcInt Seaweed Symp 5:207-215 (1966).
15)M. A. Ragan and K. W. Glombitza.Phlorotannins,
brown algal polyphenols. ProgPhycol Res 4:129-
241(1986).

Thank you for copying data from http://www.arastirmax.com